New AI collaboration could advance precision therapy in breast cancer 09 Feb 2024 A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer patients who could benefit from it. Find out more Show/Hide
ICR welcomes appointment of Aviva and Socius for new life-sciences development at The London Cancer Hub 22 Jan 2024 The Institute of Cancer Research has welcomed the appointment of a new partnership to deliver a major redevelopment project at The London Cancer Hub in Sutton. Find out more Show/Hide
ICR welcomes FDA approval of first-in-class breast cancer drug 17 Nov 2023 The ICR strongly welcomes the news that a new targeted drug, capivasertib, has been approved by the US FDA for treating the most common type of advanced breast cancer. The drug was discovered by pharmaceutical company AstraZeneca following a programme of drug discovery research at the ICR in collaboration with Astex Pharmaceuticals. Find out more Show/Hide
New MedTech firm expands liquid biopsy research at The London Cancer Hub’s Innovation Gateway 02 Oct 2023
New personalised cancer medicine company moves in at The London Cancer Hub’s Innovation Gateway 17 Nov 2022